Ohio State Navbar

Sign In

RSS Feed Regenerative Medicine News

Webinar: Protecting Patients from Harm: Ethical, Legal & Policy Responses to Domestic and International Marketing of Clinically Unproven Stem Cell Interventions

Production Assistance for Cellular Therapies (PACT) is pleased to invite you to our next PACT-sponsored Educational Web Seminar: Topic: Protecting Patients from Harm: Ethical, Legal & Policy Responses to Domestic and International Marketing of C ...[Read More]

Neurons Derived from Cord Blood Cells May Represent New Therapeutic Option

  Neurons Derived from Cord Blood Cells May Represent New Therapeutic Option July 16, 2012 - (Salk) - "Scientists at the Salk Institute for Biological Studies have found a new way-using a single protein, known as a transcription factor-to con ...[Read More]
Published: Jul-27-12
Tags: Science and Industry News

ACT Announces First Stargardt Patient Treated With Higher Dosage of Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells

  ACT Announces First Stargardt Patient Treated With Higher Dosage of Embryonic Stem Cell-Derived Retinal Pigment Epithelial Cells July 12, 2012 - (ACT) - "Advanced Cell Technology, Inc., a leader in the field of regenerative medicine, today ...[Read More]
Published: Jul-27-12
Tags: Science and Industry News

StemCells, Inc. Announces Its Human Neural Stem Cells Restore Memory in Models of Alzheimer's Disease

  StemCells, Inc. Announces Its Human Neural Stem Cells Restore Memory in Models of Alzheimer's Disease July 17, 2012 - (StemCells, Inc.) - "StemCells, Inc. today announced preclinical data demonstrating that its proprietary human neural stem ...[Read More]
Published: Jul-27-12
Tags: Science and Industry News

RO1 Opportunity in Hematopoietic Stem Cell

Contact CRMCBT if you have interest in this RO1. 614-292-5621   NIDDK has expanded the research objectives for PAS-10-046: Stimulating Hematology Investigation: New Endeavors (SHINE) (R01) to include Regulatory Determinants of Hematopoietic Stem C ...[Read More]
Published: Jul-23-12
Tags: OSU Regenerative Medicine News

New Therapy for Heart Attack Patients Approved by FDA for Clinical Trials

  New Therapy for Heart Attack Patients Approved by FDA for Clinical Trials July 9, 2012 - (CIRM) - "The therapy, which will be taken forward by Los Angeles-based biotechnology company Capricor, uses Cardiosphere Derived Cells (CDCs) to reduc ...[Read More]
Published: Jul-16-12
Tags: Science and Industry News

Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of ...

Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of ...MarketWatch (press release)Cancer Cell Article Demonstrates First Definitive Evidence for Targeting of Pol I as New Approach to Cancer Therapy. Cylene and Peter Mac Findi ...[Read More]
Published: Jul-16-12
Tags: Science and Industry News

Stem Cell Therapy: Benefits and risks

Stem Cell Therapy: Benefits and risksManila Standard TodayRecently, stem cell therapy has become a buzzword among health and wellness practitioners and enthusiasts, some of whom claim that the procedure can treat various diseases. Beauty ex perts wh ...[Read More]
Published: Jul-16-12
Tags: Science and Industry News

New therapy for blood cancer patients

New therapy for blood cancer patientsSky News AustraliaA new therapy for blood cancer patients that kills rogue cells while sparing normal ones is soon to be trialled following a landmark discovery by Melbourne scientists. Peter MacCallum Cancer Cen ...[Read More]
Published: Jul-16-12
Tags: Science and Industry News

Cardiovascular Cell Therapies To Put Pressure On U.S. Regulators

Cardiovascular Cell Therapies To Put Pressure On U.S. RegulatorsSeeking AlphaDespite the fact that the U.S. does not yet have an FDA approved cell therapy doesn't mean that there are not benefits to the treatment, nor does it mean that we won't soon ...[Read More]
Published: Jul-16-12
Tags: Science and Industry News
 Next >>